Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

This post-market study is collecting real-world data on the long-term performance of the Celect Platinum Vena Cava Filter — a small metal device placed in the inferior vena cava (the large vein returning blood to the heart) to catch blood clots that might otherwise travel to the lungs and cause a pulmonary embolism. Vena cava filters are used when patients cannot tolerate blood thinners. The Celect Platinum is designed to be retrievable, but real-world retrieval rates, complications, and filter longevity data are important for ongoing safety monitoring. Eligible participants are any adult patients who have had the Celect Platinum filter placed, who have not previously participated in the related Cook MDR-2126 study, and who consent to data collection. Patients who object to their data being used or who are unwilling to sign informed consent are excluded. Clinical and imaging data are collected from patient records at regular follow-up intervals. No additional procedures are performed as part of the study. This registry-style study matters because it supports the ongoing safety surveillance required after a medical device reaches the market, and helps physicians and regulators understand how the filter performs outside the controlled conditions of a clinical trial.